Unresectable Metastatic Colorectal Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-02-02
Clinical Trial Update: A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC [Phase 2]
A Phase II prospective trial evaluating reintroduction of mXELOXIRI for unresectable metastatic colorectal carcinoma.